Sciex_WatchNow-990x200

Register Now

Already registered?
Access the webinar here »

You must have Javascript and Cookies enabled to access this webcast.

Webinar Summary

This webinar highlights key challenges related to the recent U.S Food and Drug Administration (FDA) recall of several medicines containing Valsartan, following the detection of genotoxic impurities.

Rolf Kern from SCIEX will outline the current situation, explore the analytical methods used to characterize and quantify the impurities, and present a case study describing appropriate LC-MS methodology.

Attend this webinar to learn:
  • For insight into the current market situation with regards valsartan recall
  • To discover what the analytical method landscape looks like
  • To learn how an LC-QTOF based method can be used for both characterization and quantification of valsartan genotoxic impurities.

Speaker Information:

Rolf Kern
Rolf Kern
Technical Marketing Manager
SCIEX